tirzepatide jittery Lilly releases Zepbound® (tirzepatide) single-dose vials, expanding supply and access for adults living with obesity COMPOUNDED TIRZEPATIDE

doi: 10.3390/ijerph18115533

A patients result depends on dose, consistency, nutrition, activity, medical history, and individual response

When to compare and when not to Comparing your results to clinical trial averages is useful

Use these low-dose weeks to observe how your body responds to the weekly cycle

[2] [3] [4] Warn patients about the potential for somnolence, dizziness, confusion, difficulty concentrating, or visual effects, and advise patients against driving or operating machinery until they have gained sufficient experience on topiramate to gauge whether it adversely affects their mental performance, motor performance, and/or vision

While increased urination is not listed as a direct adverse effect in the FDA prescribing information, several factors may explain why some patients report urinating more frequently while taking this medication